Drug partnerships and global practices

Health and Place

Volumn 18, Issue 3, 2012, Pages 481-489

  Craddock, Susan ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Development; Drugs; HIV; MDR TB; PDPs; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

DISEASE TREATMENT; DRUG DEVELOPMENT; HUMAN IMMUNODEFICIENCY VIRUS; LOW INCOME POPULATION; PARTNERSHIP APPROACH; TUBERCULOSIS;

ARTICLE; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; EASTERN EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; MULTIDRUG RESISTANT TUBERCULOSIS; ORGANIZATION; PARTNERSHIP; PRIORITY JOURNAL; SOUTH AFRICA; TUBERCULOSIS;

SOUTH AFRICA;

EID: 84859221094     PISSN: 13538292     EISSN: 18732054     Source Type: Journal    
DOI: 10.1016/j.healthplace.2011.05.004     Document Type: Article

References (47)

1. Aeras Global TB Vaccine Foundation, 2009. Annual Report.
2. Aeras Global TB Vaccine Foundation and TB Alliance, 2010. Comments on the US President's Global Health Initiative (GHI), February 22 (accessed at aeras.org).
3. Ambrosino, Derek 2009. TB Alliance, personal communication, February 23.
4. Buse K., Harmer A. Seven habits of highly effective global public-private health partnerships: practice and potential. Social Science and Medicine 2007, 64:259-271.
5. Buse K., Walt G. Global public-private partnerships: part I-a new development in health?. Bulletin of the World Health Organization 2000, 78(4):549-561.
6. Casenghi, Martina, 2009. Medicins Sans Frontier Rome, personal communication, July 30.
7. Cassell, Gail, 2009. Clinical Director, Eli Lilly Drug Discovery Initiative, personal communication, March 17.
8. Cassier Maurice Flu epidemics, knowledge sharing, and intellectual property. Influenza and Public Health: Learning from Past Pandemics 2010, Earthscan Press. Tamara Giles-Vernick, S. Craddock (Eds.).
9. Craddock Susan Tuberculosis and the anxieties of containment. Networked Disease: Emerging Infections in the Global City. Series on Studies in Urban Change 2008, Blackwell Press. Harris Ali, R. Keil (Eds.).
10. Craddock Susan AIDS and the politics of violence. HIV/AIDS: Global Frontiers in Prevention/Intervention 2008, Routledge Press. C. Pope, R. White, E. Malow (Eds.).
11. Das and Das Pharmaceuticals in urban ecologies: the register of the local. Global Pharmaceuticals: Ethics, Markets, Practices 2006, 171-205. Duke University Press. A. Adriana Petryna, Lakoff, A. Kleinman (Eds.).
12. Donald, Peter, Paul van Helden, 2009. The global burden of tuberculosis-combating drug resistance in difficult times. New England Journal of Medicine. 360 (23), 2393.
13. Duffy John F. Harmony and diversity in global patent law. Berkeley Technology Law Journal 2002, 17(2):685-727.
14. Fairhead James, Leach Melissa, Small Mary Public engagement with science? Local understandings of a vaccine trial in the Gambia. Journal of Biosocial Sciences 2006, 38:103-116.
15. Geiter, Larry, 2009. Head of Clinical Development, Otsuka Pharmaceuticals, Personal communication, December 4.
16. Greenough K., Roe E. Towards a geography of bodily biotechnologies. Environment and Planning A 2006, 38:416-422.
17. Hinchliffe S., Bingham N. Securing life: the emerging practices of biosecurity. Environment and Planning A 2008, 40:1534-1551.
18. Holden Kerry, Demeritt David Democratising science? The politics of promoting biomedicine in Singapore's developmental state. Environment and Planning D: Society and Space 2008, 26:68-86.
19. Indianopolis Star, 2007. Lilly expands overseas tuberculosis fight, November 29.
20. Jasanoff Sheila Biotechnology and empire: the global power of seeds and science. Osiris 2006, 21:273-292.
21. Jones Peris AIDS Treatment and Human Rights in Context 2009, Palgrave Macmillan.
22. Kamat Vinay, Nyato Daniel Soft targets or partners in health? Retail pharmacies and their role in Tanzania's malaria control program. Social Science and Medicine 2010, 71(3):626-633.
23. Kearns Gerry, Reid-Henry Simon Vital geographies: Life, luck, and the human condition. Annals of the Association of American Geographers 2009, 99(3):554-574.
24. Kimmerling, Michael, 2010. Comments during session on fixed-dose combination pills for tuberculosis. In: 41st International Conference on Lung Health, Berlin, 14 November.
25. Labonte Ronald Healthy public policy and the World Trade Organization: a proposal for an international health presence in future world trade/investment talks. Health Promotion International 1998, 13(3):245-256.
26. Lanjouw Jean O. A new global patent regime for diseases: U.S. and international legal issues. Harvard Journal of Law and Technology 2002, 16(1):85-124.
27. Latour Bruno Reassembling the Social: An Introduction to Actor-Network Theory 2005, Oxford University Press.
28. Lee Kelly Introduction. Health Impacts of Globalization: Towards Global Governance 2003, 1-12. Palgrave. K. Lee (Ed.).
29. Liese, Berhard, Mark Rosenberg, Alexander Schratz, 2010. Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. The Lancet 375 (January 2), 67-77.
30. Lilly, 2008. The Lilly TB Drug Discovery Initiative begins work on new compounds to fill early-stage TB drug pipeline. Eli Lilly and Company News Release October 7.
31. Lilly Drug Discovery Initiative. Last visited 28/04/11. http://www.tbdrugdiscovery.org.
32. Lilly MDR-TB Partnership. Last visited 28/04/11. http://www.lillymdr-tb.com.
33. Matsumoto M., Hashizume H., Tomishige T., Kawasaki M., Tsubouchi H., Sasaki H., Shimokawa Y., Komatsu M. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. Plos Med 2006, November 28.
34. McNeeley, David 2009. Personal communication, August 14.
35. Mol A. The Body Multiple: Ontology in Medical Practice 2002, Duke University Press.
36. Nguyen V.-K. The Republic of Therapy: Triage and Sovereignty in West Africa's Time of AIDS 2010, Duke University Press, Durham.
37. Petryna Adriana When Experiments Travel: Clinical Trials and the Search for Human Subjects 2009, Princeton University Press.
38. Global Pharmaceuticals: Ethics, Markets, Practices 2006, Duke University Press. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
39. Pollock A. Transforming the critique of Big Pharma. Biosocieties 2011, 6(1):106-118.
40. Rose Nicolas The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century 2007, Princeton University Press.
41. Scheper-Hughes Nancy Rotten trade: millennial capitalism, human values, and global justice in organs trafficking. Journal of Human Rights 2003, 2(2):197-226.
42. Schneider, Ingrid The evolution of a 'European mode' of patent governance: legislation on the patenting of biotechnology in the European Union and in Germany. Living Properties: Making Knowledge and Controlling Ownership in the History of Biology 2009, Max-Planck, Institut Für Wissenschaftsgeschichte.
43. Sparke, Matt Unpacking economism and remapping the terrain of global health. Global Health Governance: Transformations, Challenges, and Opportunities Amidst Globalization 2009, 137-159. Palgrave, London.
44. TB Alliance, 2009. Global initiatives to fight tuberculosis are beginning to bring results, despite a continued lack of funds. TBA News Release January 20.
45. Waldby Catherine, Mitchell Robert Tissue Economies: Blood, Organs, and Cell Lines in Late Capitalism 2006, Duke University Press.
46. Willingham, Peg, 2010. Senior Director, External Affairs, Aeras TB Vaccine Foundation, June 16.
47. World Health Organization, 2009. Fact sheets on malaria and tuberculosis.